Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation.

Front Immunol · 2020 · PMC7821167 · PMID 33488629

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Results for pre-activated T cells showed a trend for an increased expression of PUMA, which was only significant for cells treated with 500 nM of ADV (3.9-fold, Figures 9C, D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.